Centene Co. (NYSE:CNC) Shares Sold by Diversified Trust Co

Diversified Trust Co decreased its holdings in Centene Co. (NYSE:CNC) by 64.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,921 shares of the company’s stock after selling 18,018 shares during the quarter. Diversified Trust Co’s holdings in Centene were worth $601,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of CNC. Park Place Capital Corp grew its position in Centene by 1,190.0% in the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after buying an additional 357 shares in the last quarter. Private Trust Co. NA increased its stake in shares of Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after acquiring an additional 332 shares during the period. True Wealth Design LLC bought a new stake in Centene during the third quarter worth approximately $66,000. Venturi Wealth Management LLC lifted its position in Centene by 77.3% in the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after purchasing an additional 507 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in shares of Centene by 104.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company’s stock valued at $82,000 after purchasing an additional 630 shares during the period. 93.63% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CNC shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 target price on shares of Centene in a research note on Wednesday, December 11th. Wells Fargo & Company lowered their price objective on shares of Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Oppenheimer cut their target price on shares of Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, December 13th. Truist Financial dropped their price target on Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a report on Friday, December 13th. Finally, Robert W. Baird reduced their price objective on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, Centene has a consensus rating of “Moderate Buy” and a consensus target price of $80.92.

Insider Buying and Selling

In other news, Director Thomas Greco bought 17,000 shares of the stock in a transaction on Wednesday, December 18th. The shares were purchased at an average price of $59.75 per share, for a total transaction of $1,015,750.00. Following the completion of the purchase, the director now directly owns 19,309 shares of the company’s stock, valued at $1,153,712.75. This trade represents a 736.25 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sarah London purchased 4,117 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $60.80 per share, with a total value of $250,313.60. Following the completion of the purchase, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 45,010 shares of company stock worth $2,660,276. 0.33% of the stock is owned by company insiders.

Centene Trading Down 2.3 %

Shares of NYSE CNC opened at $61.72 on Friday. The firm has a market capitalization of $31.16 billion, a PE ratio of 10.72, a PEG ratio of 0.78 and a beta of 0.45. Centene Co. has a one year low of $55.03 and a one year high of $81.42. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The business has a 50-day moving average price of $60.09 and a two-hundred day moving average price of $67.45.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.